![(4AR,7aS)-Octahydro-1H-pyrrolo[3,4-b]pyridine dihydrochloride chemical structure](/media/structures/PBDBVGLZVIIZNU-GPJOBVNKSA-N.svg)
(4AR,7aS)-Octahydro-1H-pyrrolo[3,4-b]pyridine dihydrochloride
- CAS
- 2306255-12-7
- Formula
- C7H16Cl2N2
- MW
- 199.12 g/mol
VQ-049176
Impurity reference standards
Moxifloxacin impurities & reference standards
Characterised Moxifloxacin impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
60reference materials
1nitrosamine impurities
COAHPLC · NMR · MS on request
Parent API: Moxifloxacin
186826-86-8 · C21H25ClFN3O4
![(4AS,7aR)-Octahydro-1H-pyrrolo[3,4-b]pyridine dihydrochloride chemical structure](/media/structures/PBDBVGLZVIIZNU-JFYKYWLVSA-N.svg)
(4AS,7aR)-Octahydro-1H-pyrrolo[3,4-b]pyridine dihydrochloride
- CAS
- 2306249-33-0
- Formula
- C7H16Cl2N2
- MW
- 199.12 g/mol
VQ-049177
![(4AS,7aS)-Octahydro-1-methyl-1H-pyrrolo[3,4-b]pyridine chemical structure](/media/structures/QVLUVOZDWSAEIP-JGVFFNPUSA-N.svg)
(4AS,7aS)-Octahydro-1-methyl-1H-pyrrolo[3,4-b]pyridine
- CAS
- 151213-45-5
- Formula
- C8H16N2
- MW
- 140.23 g/mol
VQ-026787
![(S,S)-2,8-Diazabicyclo[4.3.0]nonane chemical structure](/media/structures/KSCPLKVBWDOSAI-NKWVEPMBSA-N.svg)
(Z)-Ethyl 3-ethoxy-2-(2,4,5-trifluoro-3-methoxybenzoyl)acrylate
- CAS
- 122375-85-3
- Formula
- C15H15F3O5
- MW
- 332.27 g/mol
VQ-049172
1-Cyclopropyl-6,7-difluoro-8-hydroxy-4-oxo-1,4-dihydro-quinoline-3-carboxylic Acid
- CAS
- 154093-72-8
- Formula
- C13H9F2NO4
- MW
- 281.21 g/mol
VQ-026783
1-Cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid
- CAS
- 94695-52-0
- Formula
- C13H8F3NO3
- MW
- 283.2 g/mol
VQ-026785
1-Cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Ethyl Ester
- CAS
- 94242-51-0
- Formula
- C15H12F3NO3
- MW
- 311.25 g/mol
VQ-038517
3-Quinolinecarboxylic acid, 1- cyclopropyl-7-fluoro-1,4- dihydro-6,8-dimethoxy-4-oxo-, ethyl ester
- CAS
- 2489671-14-7
- Formula
- C17H18FNO5
- MW
- 335.33 g/mol
VQ-032017
![6-Benzyl-5,7-dioxooctahydropyrrolo[3,4-b]pyridine chemical structure](/media/structures/RRBLNPCNHNHAFW-UHFFFAOYSA-N.svg)
6-Benzyl-5,7-dioxooctahydropyrrolo[3,4-b]pyridine
- CAS
- 128740-13-6
- Formula
- C14H16N2O2
- MW
- 244.29 g/mol
VQ-038511
![7-((4AS,7aS)-1-(2-Carboxyethyl)octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid chemical structure](/media/structures/KKKHXDXIMHPJDE-SCLBCKFNSA-N.svg)
7-((4AS,7aS)-1-(2-Carboxyethyl)octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid
- CAS
- 2489671-20-5
- Formula
- C24H28FN3O6
- MW
- 473.5 g/mol
VQ-049170
7-(3-(2-Carboxyethyl)-4-(hydroxyamino)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- CAS
- 1395056-42-4
- Formula
- C21H24FN3O7
- MW
- 449.4 g/mol
VQ-035016
7-Amino-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid
- CAS
- 172426-88-9
- Formula
- C14H13FN2O4
- MW
- 292.26 g/mol
VQ-026784
7-Amino-1-cyclopropyl-6-fluoro-8-methoxyquinolin-4(1H)-one
- CAS
- 1467586-86-2
- Formula
- C13H13FN2O2
- MW
- 248.25 g/mol
VQ-038514
![cis-Octahydropyrrolo[3,4-b]pyridine chemical structure](/media/structures/KSCPLKVBWDOSAI-RQJHMYQMSA-N.svg)
Ethyl3-oxo-3-(2,4,5-trifluoro-3-Methoxyphenyl)propanoate
- CAS
- 112811-68-4
- Formula
- C12H11F3O4
- MW
- 276.21 g/mol
VQ-049164
FAQs — Moxifloxacin impurities
Which Moxifloxacin impurities do you supply?
We list 60 Moxifloxacin-related reference materials, including process impurities, degradation products, nitrosamine impurities and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Moxifloxacin impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Moxifloxacin impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Moxifloxacin impurity standards
We reply within one business day with price, pack options, lead time and documentation.